Immiscible Solvents Used In The Process, Or Product Thereof Patents (Class 530/229)
  • Synthetic polypeptides and antibodies related to epstein-barr virus nuclear antigen
    Patent number: 5717065
    Abstract: Antigens, immunogens, inocula, antibodies, and particularly diagnostic methods and systems relating to Epstein-Barr virus nuclear antigen (EBNA) are disclosed. The diagnostic methods and systems utilize a synthetic, random copolymer polypeptide containing about 6 to about 40 amino acid residues having a sequence corresponding to the sequence of a CMV-encoded polypeptide antigen. The diagnostic methods and systems are particularly useful in identifying infections mononucleosis during its acute phase.
    Type: Grant
    Filed: August 9, 1988
    Date of Patent: February 10, 1998
    Assignee: The Scripps Research Institute
    Inventors: Gary Rhodes, Richard S. Smith